MarginsXMarginsX
Home › Markets › Health Care › NVST

Envista Holdings Corporation (NVST)

NVST trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$24.03
-1.88% on the day
Market cap
$3.9B
Mid cap
Revenue · 2025
$2.7B
+8.3% on 2024
Net income · 2025
$47.0M
1.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1757073/000175707326000011/0001757073-26-000011-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerNVST on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2019
SEC CIK0001757073
SEC industry codeDental Equipment & Supplies
Incorporated inDE

Financials · 2025

LineValue
Revenue$2.7B
Net income$47.0M
Operating income$216.1M
Net margin1.7%
Operating margin7.9%
Revenue growth+8.3%
Cash$1.2B
Total assets$5.7B
P/E (computed)82.0×
P/S (computed)1.4×

Warning signs

Cash runway
Cash-flow positive
$1.2B cash at October 2, 2026
Share count, 1 year
-2.5%
2025-10-24 to 2026-10-30 · -6.5% over 3 years
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
-$510K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$1.2B cash; operating cash flow $75.5M a quarter.Report 2026-10-02
Shares outstanding160,344,938 (2026-10-30); 164,426,233 a year earlier; 171,402,370 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-11-09
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Irvine, California, United StatesPCAOB Form AP 2026-02-26
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $510K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-10-02
$691.5M$508.3M$77.9M$1.2B$1.4B$2.9B10-Q 2026-11-04
Q2 2026
2026-07-03
$730.5M$53.7M$119.2M$1.1B$1.4B$2.9B10-Q 2026-08-05
Q1 2026
2026-04-03
$705.5M$38.7M-$3.3M$1.1B$1.4B$2.8B10-Q 2026-05-06
Q4 2025
2025-12-31
$750.6M$32.9M$108.0M$1.2B$1.4B$2.7B10-K 2026-02-12
Q3 2025
2025-09-26
$669.9M-$30.3M$78.7M$1.1B$1.4B$2.6B10-Q 2026-11-04
Q2 2025
2025-06-27
$682.1M$26.4M$88.7M$1.1B$1.4B$2.6B10-Q 2026-08-05
Q1 2025
2025-03-28
$616.9M$18.0M$300K$1.1B$1.5B$2.5B10-Q 2026-05-06
Q4 2024
2024-12-31
$652.9M$1.2M$132.4M$1.1B$1.5B$2.5B10-K 2026-02-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B22026-11-12
Latest annual report10-K2026-02-12
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-07

Source: SEC EDGAR submissions feed, 561 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-2.7%
1 month+8.1%
3 months-12.8%
Year to date+12.8%
1 year+23.1%
From 52-week high-19.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
HTFLHeartflow Inc.$46.86-3.30%$4.1B
STVNStevanato Group S.p.A.$15.53-1.71%$4.2B
PLSEPulse Biosciences Inc Common Stock (DE)$46.36-8.09%$3.4B
ICUIICU Medical Inc.$181.87+1.45%$4.5B
IRTCiRhythm Holdings Inc.$90.83-1.18%$3.1B
VVVVvVARDIS Holding AG$16.00-3.03%$2.9B
MMSIMerit Medical Systems Inc.$86.35-0.32%$5.2B
MMEDMiniMed Group Inc.$18.65+3.67%$5.2B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier